Lorenzo Barba retweeted
Our new paper out today on @NatureComms! We investigated brain-derived and big tau isoforms in #Alzheimer and #ALS and developed a new assay for brain-derived p-tau217.
Tau isoform mapping across tissues and biofluids reveals a signature distinguishing Alzheimer’s disease from amyotrophic lateral sclerosis idp.nature.com/authorize?res…
Excited to see our latest work on serum synaptim markers out in @JNNP_BMJ !
Nice collaboration of German, Italian and Spanish groups 🧠
@s_rumeileh
jnnp.bmj.com/content/early/2…
Lorenzo Barba retweeted
Check out our new study!
☑️p-tau 181 and 217 in blood are not as specific for AD as previously thought,
☑️they are also elevated in the blood of patients with ALS,
☑️IHC and MS analyses disclosed both p-tau species in muscle biopsies from ALS cases.
nature.com/articles/s41467-0…
Very pleased to see our article out! We explored for the first time CSF synaptic biomarkers (SNAP-25, ng, beta-synuclein) in MS and found that reduced biomarker levels are associated with brain atrophy at MRI and cognitive impairment 🧠
@s_rumeileh
link.springer.com/article/10…
Lorenzo Barba retweeted
Fantastic morning at the #DGN Kongress 2024 Berlin, discussing #SynapticHealth and synaptic biomarkers in blood, CSF, PET and pathology. Thanks to Markus Otto, Patrick Oeckl, Dietmar Thal @lorbarba and @M_Malpetti and the great audience @wbic_cam @DementiasUK
Lorenzo Barba retweeted
🚨Just published in @ESOstroke: Antithrombotic drugs for carotid artery dissection: Updated systematic review🚨
Weak evidence for #antiplatelets as standard for #carotidarterydissection. Treatment individualization is warranted!
Full article here: journals.sagepub.com/doi/10.…
Lorenzo Barba retweeted
Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial - The Lancet Neurology thelancet.com/journals/laneu…
Lorenzo Barba retweeted
When small vessel disease #SVD is mixed with #CAA signs, amyloid PET may help identify people at higher risk of cerebral bleeding 🩸🧠
Have a look at our study out in
@GreenJournal
@BenStorti
@NeuroBesta
@AUSLRomagna
@CAA_Disease
@ISA_AII_Young
neurology.org/doi/10.1212/WN…
Lorenzo Barba retweeted
Is left atrial appendage occlusion a valuable treatment option for patients with atrial fibrillation and #breakthroughstroke despite anticoagulation therapy? @davidseiffge @boersma_lucas ja.ma/47BEHMx
Lorenzo Barba retweeted
Barba et al. review the co-occurrence of Alzheimer's disease and Lewy body disease pathologies, and consider the diagnostic and prognostic value of neuroimaging and fluid biomarkers. tinyurl.com/mt5cxbuv
Lorenzo Barba retweeted
Barba et al. review the co-occurrence of Alzheimer's disease and Lewy body disease pathologies, and consider the diagnostic and prognostic value of neuroimaging and fluid biomarkers. tinyurl.com/mt5cxbuv
Extraordinarily excited for our work to be published in @Brain1878 today!
We extensively discuss the clinical and diagnostic implications of #Alzheimer’s disease copathology in Lewy body disease 🧠
@s_rumeileh
@fedemassa88
@mattfos89
@unimedizinhalle
academic.oup.com/brain/advan…
Lorenzo Barba retweeted
This fantastic study shows ALL even low levels of physical activity benefit the brain by reducing stroke risk. 🧠 🏃
👇
bit.ly/3IyFq5n
By
@RaffaeleOrnello
@s_rumeileh
@mattfos89
@fededs00
@MicheleRomoli
@luciodanna2
@Simona_Sacco_
@lorbarba et al
Lorenzo Barba retweeted
Curious about the feasibility of mechanical thrombectomy after ischemic stroke in the context of cardiac diseases? #AHAJournals #Review @luciodanna2 @s_rumeileh @giovmerl @mattfos89 @lorbarba @simona_sacco_ @NguyenThanhMD ahajrnls.org/3W0GjLI
Excited for our review on MT in AIS due to cardiological disorders 🧠🫀
A great effort from a great team!
@luciodanna2
@s_rumeileh
@mattfos89
@MicheleRomoli
Finally Out our review exploring for the first time the safety and efficacy Mechanical Thrombectomy in Acute Ischemic Stroke Attributable to Cardiological Diseases | Journal of the American Heart Association ahajournals.org/doi/10.1161/… @Simona_Sacco_ @mattfos89 @ESOstroke
Happy to share our last publication on two new CSF markers of neurosecretory pathways impairment (VGF and neuroserpin) 💧 those biomarkers were associated with AD pathology and cognitive impairment in AD and LBD 🔬🧠
@s_rumeileh
jns-journal.com/article/S002…
Only 12 cases in literature of PRES associated with administration of antibiotics. We reviewed these cases to raise attention on this not negligible neurological syndrome 🧠🦠💊
@s_rumeileh
@mattfos89
@luciodanna2
link.springer.com/article/10…
Lorenzo Barba retweeted
This fantastic study shows ALL even low levels of physical activity benefit the brain by reducing stroke risk. 🧠 🏃
👇
bit.ly/3IyFq5n
By
@RaffaeleOrnello
@s_rumeileh
@mattfos89
@fededs00
@MicheleRomoli
@luciodanna2
@Simona_Sacco_
@lorbarba et al
Lorenzo Barba retweeted
ENRICH trial in @NEJM shows improved outcomes for lobar ICH treated with minimally invasive surgery. Surgery not effective for basal ganglia ICH. 30 day mortality lower with surgical rx. A major development in ICH rx options @WorldStrokeOrg @ESOstroke
nejm.org/doi/full/10.1056/NE…
Lorenzo Barba retweeted
We are VERY pleased to have published this paper showing that even low levels of physical activity reduce stroke risk. Absolutely fantastic paper which I believe will benefit and motivate many patients. Small changes can be real meaningful
"All levels of LTPA can be beneficial for stroke prevention. People should be encouraged to be physically active even at the lowest levels." Now online! jnnp.bmj.com/content/early/2… @RaffaeleOrnello , @Simona_Sacco_ , @mattfos89 ,@lorbarba , @s_rumeileh , @luciodanna2 ,@MicheleRomoli





















